Market closed
Promis Neurosciences Inc/$PMN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Promis Neurosciences Inc
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Ticker
$PMN
Sector
Trading on
Industry
Biotechnology
Headquarters
Toronto, Canada
Employees
8
Website
PMN Metrics
BasicAdvanced
$21M
5.97
$0.11
0.29
-
Price and volume
Market cap
$21M
Beta
0.29
52-week high
$0.87
52-week low
$0.51
Average daily volume
33K
Financial strength
Current ratio
8.525
Quick ratio
6.006
Interest coverage (TTM)
-219.18%
Management effectiveness
Return on assets (TTM)
-51.21%
Return on equity (TTM)
27.46%
Valuation
Price to earnings (TTM)
5.97
Price to book
1.27
Price to tangible book (TTM)
1.27
Price to free cash flow (TTM)
-0.61
Growth
Earnings per share change (TTM)
-109.97%
3-year earnings per share growth (CAGR)
-60.13%
PMN News
AllArticlesVideos
ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
GlobeNewsWire·1 month ago
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer's Disease/Parkinson's Disease 2025 International Conference
GlobeNewsWire·1 month ago
ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Promis Neurosciences Inc stock?
Promis Neurosciences Inc (PMN) has a market cap of $21M as of May 05, 2025.
What is the P/E ratio for Promis Neurosciences Inc stock?
The price to earnings (P/E) ratio for Promis Neurosciences Inc (PMN) stock is 5.97 as of May 05, 2025.
Does Promis Neurosciences Inc stock pay dividends?
No, Promis Neurosciences Inc (PMN) stock does not pay dividends to its shareholders as of May 05, 2025.
When is the next Promis Neurosciences Inc dividend payment date?
Promis Neurosciences Inc (PMN) stock does not pay dividends to its shareholders.
What is the beta indicator for Promis Neurosciences Inc?
Promis Neurosciences Inc (PMN) has a beta rating of 0.29. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.